This three-day event will develop upon the previous, highly successful meeting to further provide focused and in depth industry, regulatory and scientific perspectives in terms of what the factors are that hinder the progression of biologics in clinical development. Industry experts will talk about their experiences and give insight into the vital components that make up a successful early-stage strategy for biologic studies...

More...